在患有胃肠道出血的患者中与铁相关的伪黑色素病杜德尼:一个病例报告
Sarah Saleh1, Houssein Chebbo1, Karam Karam2
1Faculty of Medicine, University of Balamand, Beirut, Lebanon.
The American journal of case reports
|October 11, 2024
概括
伪黑色素质双胞胎病 (PD) 是一种罕见的双胞胎发现,与慢性疾病和药物有关. 这个案例突出了患有缺铁性贫血的患者的PD,这表明口服铁疗法是潜在的原因.
科学领域:
- 胃肠病学 胃肠病学
- 病理学 病理学 病理学
- 内镜检查是指内镜检查.
背景情况:
- 伪黑色双胞胎病 (Pseudomelanosis duodeni,PD) 是一种罕见的内镜检测结果,在靠近的十二指肠中发现暗色素斑点.
- 患PD与ESRD,高血压,糖尿病等慢性疾病以及口服铁补充剂等药物有关.
研究的目的:
- 在患有下胃肠道出血的患者中报告 Pseudomelanosis duodeni (PD) 的病例.
- 调查口服铁疗法与PD发展之间的潜在联系.
主要方法:
- 进行了食管胃肠透镜 (EGD) 和结肠镜检查,以评估贫血和直肠出血.
- 十二指肠活检被分析为他的病理学,包括珀尔的普鲁士蓝色染色用于检测铁.
主要成果:
- EGD揭示了对PD可疑的发现,通过显示有色素巨细胞与铁沉积的活检证实了这一发现.
- 该患者有铁缺乏性贫血病史,接受了口服铁补充剂治疗,并出现了出血.
结论:
- 伪黑色素质双胞胎病是一种良性十二指甲状腺疾病.
- 在这种情况下,口服铁疗法可能是导致PD发展的因素.
- 需要进一步的研究来了解PD的长期结果和管理.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
47
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
47
Peptic Ulcer Disease I: Introduction
141
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
141
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
94
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
94
Inflammatory Bowel Disease I: Ulcerative Colitis
147
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
147
Peptic Ulcer Disease II: Pathophysiology
306
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
306
Inflammatory Bowel Disease II: Crohn's Disease
191
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
191


